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Abstract: 
Background: Population-based data regarding stroke among women are scarce in developing 
countries. This study was designed to determine whether sex differences exist in stroke incidence, 
mortality, and recurrence. 
Methods: The Mashhad Stroke Incidence Study (MSIS) is a population-based cohort study in Iran. 
For a period of one year, all patients with stroke in three geographical regions in Mashhad were 
recruited and then followed up for 5 years. Age- and sex-specific crude incidence rates were 
standardized to the WHO New World Population. Male/female incidence rate ratios were assessed 
for all age groups and all subtypes of first ever stroke (FES). 
Results: The annual crude incidence rate of FES (per 100000 population) was similar in men (144; 
95% CI: 129-160) and women (133; 95% CI: 119-149). Standardized FES annual incidence rates 
were 239 (95% CI: 213-267) for men and 225 (95% CI 200-253) for women, both greater than in 
most western countries. There were no significant differences in stroke recurrence or case-fatality 
between women and men during early and long-term follow up 
Conclusion: The similar incidence of stroke between men and women highlights the importance 
of equally prioritizing adequate preventive strategies for both sexes. The greater relative 
incidence of stroke in women in Mashhad compared with other countries warrants improvement 
of primary and secondary stroke prevention.  
Introduction: 
The underlying ethology, incidence, mortality and outcomes of stroke vary substantially between 
men and women (1). Although age-specific stroke rates are greater in men, women have more 
absolute numbers of stroke and poorer outcomes than men due to longer life expectancy and higher 
incidence rates at age >85 years (1,2). Stroke may also be more severe in women (3), and with a 
greater 30-day case fatality (4). 
Valid data regarding women stroke are scarce, particularly in the low/middle-income countries. 
The current study is designed to investigate sex-specific differences in stroke incidence, mortality 
and recurrence during five-year follow up in Mashhad, Iran. 
Methods and patients: 
Population:  
The present study is part of the Mashhad Stroke Incidence Study (MSIS). The methods of the 
MSIS have been previously described (5, 6). Using multiple overlapping sources all individuals 
with an acute stroke including ischemic stroke (IS), intracerebral hemorrhage (ICH), subarachnoid 
hemorrhage (SAH), and undefined stroke (US) and were recruited and followed for 5 years for 
any changes in health condition (5) (Figure-1; online supplemental data). The study was approved 
by the Ethics Committee of the Mashhad University of Medical Sciences. 
Baseline assessment  
We collected details of clinical history, neurological examinations, neuroimaging information, 
vascular risk factors and socioeconomic status (education, occupation, household income) for all 
patients. Specific questions regarding menstruation, pregnancies, use of oral contraceptive pills 
and menopause were also obtained. 
Statistical analysis:  
The male/female (M/F) age-adjusted incidence rate ratios were assessed for all age groups and all 
subtypes of initial stroke. Using the direct method (7) age and sex-specific crude incidence rates 
were standardized to the WHO New World Population (WHO 2000-2025) standard population. 
Kaplan-Meier curves were used to compare the cumulative risk of death. Competing risk analysis 
was used to determine the cumulative incidence of recurrent stroke, with death considered as a 
competing event for recurrence. Prognostic variables associated with death were assessed using 
Cox proportional hazard, backward stepwise regression analysis. P≤ 0.05 (two sided) was 
considered to be statistically significant. R statistical software was used to run competing risk 
analysis and cause-specific Cox proportional hazard regression with 95% CIs. SPSS statistical 
software (version 16, SPSS Inc., Illinois, and USA) was used for the rest of the statistical analyses. 
Patients who were not completely followed were included in the competing risk and Kaplan-Meier 
analyses until they were followed. 
Results:  
During the study period, a total of 327 (52.4%) men and 297 (47.6%) women with first-ever stroke 
(FES) were identified. The mean age of stroke was similar between men (65.0 ± 14.6) and women 
(64.1 ± 15.0; p=0.6). Women were more likely than men to have a history of hypertension 
(p<0.001), to be single, divorced or widowed (p<0.001), to be unemployed or a home-maker 
(p<0.001) and have an educational level of less than 12 years (p-value<0.001). Men more often 
had a history of coronary artery disease, including myocardial infarction ≤ 27 days (p=0.04) and 
≥ 28 days before stroke (p=0.01) than women (Table-1). Despite all attempts, 69 patients were not 
accessible to follow up due to change of address or loss of contact; 3 immediately after discharge 
from hospital, 5 during the first year and 61 patients after first year (Table-1: online supplemental 
data).  
Incidence:  
The age-specific crude annual incidence rates of stroke are shown in the table 2. The incidence of 
FES increased similarly in both sexes with each decade of life, with a significant rise after the age 
45. There were no differences in overall standardized FES incidence rates between men (239, 95% 
CI: 213-267) and women (225, 95% CI: 200-253) either. Similarly, no sex differences were found 
for any age group. The total M/F incidence ratio was 1.06 (95% CI: 0.9-1). 
Stroke Subtypes 
The total male/female incidence rate ratios were similar across all types of stroke (Table-3). Age-
adjusted incidence rate of ICH among women <45 years were almost 3.5 fold higher than men in 
same age group (F/M ratio: 3.5; 95% CI: 1-11). No significant differences were observed across 
all subtypes of IS (Table-2; online supplemental data). 
Stroke Recurrence  
Women and men had similar rate of recurrent stroke either at one year (women: 5.4% vs men: 
5.5%, Log rank P= 0.7) and five years after index stroke (men: 13.2% vs women: 13%, Log rank 
P= 0.7) (Figure-1). Multivariate cox proportional hazard model revealed that only the National 
Institutes of Health Stroke Scale (NIHSS; HR: 1.05, 95% CI: 1.01-1.09) and age (HR: 1.03, 95% 
CI: 1.01-1.04) were significantly associated with five-year recurrence rate for men. 
Case fatality  
Case fatality was similar in women and men at 30 days (women: 20.4% vs men: 21.2%), one year 
(women: 31.3% vs men: 35.5%) and five years (women: 53.8% vs men: 60.5%) with no 
statistically significant differences (Log-rank P: 0.1) (Figure-2). Stroke itself was the most 
common reason for death in both women (43.2%) and men (39.7%; p= 0.9).  
In univariable Cox proportional hazard regression, increasing age, NIHSS at admission, history of 
atrial fibrillation and having less than 12 years of education were associated with an increased 5-
year risk of death for both sexes (Table-4). Furthermore, other sex-specific factors increasing risk 
of five-year death among men and women are also shown in table 4.   
The multivariable Cox proportional hazard model evidenced that advanced age (men: HR: 1.03, 
95% CI: 1.02-1.04; women: HR: 1.03, 95% CI: 1.02-1.05) and NIHSS (men: HR: 1.11, 95% CI: 
1.09-1.12; women: HR: 1.12, 95% CI: 1.1-1.14) were significantly increased the risk of death 
during five-year after FES in both men and women. Furthermore, a history of hypertension (HR: 
1.5, 95% CI: 1.1-2.1) was also significantly associated with increased five-year case fatality for 
men. Among women, a history of atrial fibrillation (HR: 2.04, 95% CI: 1.3-3.2), current smoking 
(HR: 1.8, 95% CI: 1.1-3) and having less than 12 years of education (HR: 7.3, 95% CI: 1.7-30.9) 
were significant predictors of five-year case fatality. 
Discussion  
Our study has important implications regarding sex-specific differences in stroke epidemiology. 
In contrast to many studies, the annual incidence rate of FES, the mean age at stroke onset and 
long-term risk of recurrent stroke and mortality were similar in our male and female subjects. In 
addition, the level of education had a significant effect on the mortality rate among women. 
Stroke incidence and mortality vary significantly between men and women. As compared to some 
high-income countries (8–10), we observed higher age-adjusted incidence rates of FES for both 
sexes in the MSIS. This finding can be probably due to a relatively younger age distribution in 
Mashhad (5). In many studies, stroke reported more frequently in men (about 33%) than women 
(4). Such differences can be partially explained by an overall longer life expectancy among women 
(11). In our study, although the annual incidence rate of FES among men was 6% higher than 
women, this figure did not reach a significant value. This is an important finding, highlighting a 
greater burden of stroke among women in the MSIS. In addition, the age of stroke also varied in 
men and women. In a systematic review, the mean age of stroke among women and men were 72.9 
years and 68.6 years, respectively (4). We found that a relatively younger age for stroke 
occurrence, with a similar mean age at stroke onset among women and men (at ~65 years). Having 
added this finding to a relatively higher rate of stroke in women in our population indicates a 
dramatically higher burden of women stroke, emphasizing a target oriented plan to control stroke 
in women.  
To assess the possible reasons of the higher incidence rate of women strokes, we reviewed vascular 
and demographic risk factor, stratifying subjects according to their age and menopausal status. In 
total, hypertension was more frequently observed in women than men. In addition, socioeconomic 
status was also different, with a higher rate of unemployment and low educational level (<12 years) 
in women. These findings may partially explain our significant difference with many studies which 
needs long-term public plans to fight against stroke in women. 
Studies regarding stroke etiology according to sex are also scarce. Some studies showed higher 
incidence rates of ICH and IS among men than those in women (3, 4, 9). Such differences might 
be explained by the difference in the frequency of vascular risk factors (i.e. smoking, addiction 
and alcohol overuse among men) (3). In contrast, despite the presence of different vascular risk 
factors, our women and men had similar incidence rates across all subtypes of stroke. However, 
among patients with ICH, women <45 had significantly a higher incidence of stroke (3.5 fold) 
compared to men at similar age groups. Inconsistent with previous reports (4, 12), SAH was more 
common among men in Mashhad; however, due to relatively low sample size in SAH, this finding 
should be taken into account with cautions. 
We did not find a significant difference in the overall mortality and recurrence rates of stroke 
among men and women. A systematic review showed that the 30-day case fatality of stroke was 
1.25 fold greater in women than men (4) which could be attributable to higher mean age of women 
than men at time of first stroke. The lack of difference in case fatality in our study, might be due 
to the age distribution of stroke in men and women in our population. In the MSIS, education less 
than 12 years was also an independent predictor of five-year death in women. In the Framingham 
study, the highest stroke case fatality for men and women was attributed to SAH and ICH (13). A 
similar pattern was observed in our study with the highest 30-day cumulative rate of death in SAH 
(for men) and ICH (for women). Women had a higher incidence of ICH at younger ages and died 
more commonly than men due to ICH within 30-day after the index stroke. This might be explained 
by a larger prevalence of hypertension in our women than men.  
There are some limitation which may affect our results. We were not able to completely follow up 
eleven percent of patients during five-year period of study. Among these patients, both male and 
female were significantly younger and had lesser severity of stroke than those who were followed 
up. So their inclusion may have somewhat modified the risk factors independently associated with 
the risk of recurrence and death for men and women if any of these people had a recurrent event 
or died.  
To control any source of bias in data collection at baseline and follow up period for men and 
women, we reviewed the frequency of patients admitted in hospitals versus those who solely 
managed in the community and also any differences in basic characteristic among those with and 
without complete follow up time. Hospital admission rates were similar between both sexes 
(62.4% of men and 64.6% women). Therefore, we believe that we were able to capture all men 
and women with stroke accurately. Finally, an almost door- to -door survey with the help of about 
1000 volunteers provided a detailed information about any possible stroke in the study area. 
Dropout rates during follow up period were similar between men and women. In addition, the list 
of missing variables, those who lost to follow and those without imaging (undefined strokes) were 
not significantly different between both sexes.   
In summary, a relatively high incidence of stroke among women with a higher rate of death in  less 
educated patients warrant a thorough prevention methods not only to control risk factors but also 
to improve public health general knowledge. Furthermore, as women tend to live longer, according 
to the higher life expectancy in Iran (male/female: 74/77), the fact that there is no difference in the 
age of onset of stroke, is another disadvantage for women which will live longer with their 
disability. 
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Table 1. Characteristics of the Mashhad stroke incidence Study cohort by sex. 
Variable 
Male 
N (%) 
Female 
N (%) 
P value 
Age (mean ± SD) 64.99 ±14.6 64.11 ± 15.03  
Hypertension 165 (50.9) 208 (70.3) <0.001 
History of Transient Ischemic Attack 26 (8) 23 (7.7)  
Diabetes 98 (30.2) 89 (30)  
Hyperlipidemia 70 (21.7) 78 (26.6)  
Atrial fibrillation 24 (7.6) 28 (9.7)  
History of acute myocardial infarction ≤27 
days before stroke 
9 (2.8) 2 (0.7) 0.04 
History of acute myocardial infarction ≥28 
days before stroke 
39 (11.9) 18 (6.1) 0.01 
History of Dementia 14 (4.3) 9 (3)  
Current smoker 61 (18.7) 37 (12.5) 0.03 
Ex-smoker 66 32 0.001 
Addiction 54 (16.5) 24 (8.1) 0.001 
Alcohol (daily drinker) 18 (5.6) 0 <0.001 
Family history of stroke 54 (16.5) 58 (19.5)  
Married 284 (87.7) 180 (61.2) <0.001 
Household income 
Low 165 (50.5) 171 (57.6)  
Medium 132 (40.4) 106 (35.7)  
High 30 (9.2) 20 (6.7)  
Patient`s occupation 
Work pre stroke 178 (58.4) 14 (4.8) 
<0.001 
Retired 86 (26.5) 5 (1.7) 
Disabled 7 (2.2) 2 (0.7) 
Unemployed or home maker 54 (16.6) 270 (92.8) 
Education 
≤ 12 years 233 (71.7) 261 (90) 
<0.001 
≥ 13 years 92 (28.3) 29 (10) 
NIHSS at admission 10.9 ± 10.34 10.7 ± 10.2  
*Abbreviation (in alphabetic order): National institutes of health stroke scale (NIHSS)  
Table 2. The age and sex specific and WHO age-adjusted incidence rates of first-ever stroke in Mashhad, Iran. 
Age group 
(years) 
Men  Women  
Male/Female 
ratio (95% CI)* Population Number Incidence (95% CI)) 
 
Population Number 
Incidence (95% 
CI)) 
 
<45 186087 26 14 (9-20)  183256 32 17 (12-24)  0.8 (0.5-1) 
45-54 20681 51 247 (186-321)  19915 42 211 (154-282)  1.17 (0.8-2) 
55-64 10146 69 680 (533-855)  9950 66 663 (517-838)  1.03 (0.7-1) 
65-74 6820 83 1217 (976-1500)  6283 73 1162 (917-1452)  1.05 (0.8-1) 
75-84 3109 77 2477 (1969-3077)  2835 63 2222 (1723-2823)  1.1 (0.8-1.5) 
>85 556 21 3777 (2407-5664)  591 21 3553 (2265-5329)  1.06 (0.6-2) 
Total 227399 327 144 (129-160)  222830 297 133 (119-149)   
WHO age-
adjusted 
239 (213-267) 
 
225 (200-253) 
 
1.06(0.9-1) 
*Male/Female age-adjusted incidence rate ratio; CI, Confidence Interval; WHO, World Health Organization; Incidence is per 100,000 
population per year. 
  
Table 3. The age and sex specific incidence rates per 100000 along with the male-female incidence ratio for all subtypes of first ever stroke. 
Age 
groups 
Ischemic Stroke   Intracerebral Hemorrhage 
Male  Female Male/Female 
ratio  
(95% CI)* 
 Male  Female Male/Female 
ratio  
(95% CI)* 
Number 
Incidence 
rate 
 
Number 
Incidence 
rate 
 
Number 
Incidence 
rate 
 
Number 
Incidence 
rate 
<45 19 10  22 12 0.9 (0.5-2)  2 1.1  7 3.8 0.3(0.06-2) 
≥45 245 593  226 571 1.03 (0.9-1)  43 104  28 70.7 1.5(1.02-2) 
Total 264 116.1  248 111.3   45 19.7  35 15.7  
WHO age-
adjusted 
172 (152-195) 
 
168 (147-190) 1.02 (0.9-1) 
 
30 (22-40) 
 
22 (15-31) 1.3 (0.9-2) 
 
Table 3 continued: 
Age 
groups 
Subarachnoid Hemorrhage   Undefined Stroke 
Male  Female Male/Female 
ratio  
(95% CI)* 
 Male  Female Male/Female 
ratio  
(95% CI)* 
Number 
Incidence 
rate 
 
Number 
Incidence 
rate 
 
Number 
Incidence 
rate 
 
Number 
Incidence 
rate 
<45 3 1.6  2 1.1 1.5(0.4-7)  2 1.1  1 0.5 2 (0.5-13) 
≥45 5 12.1  4 10.1 1.2(0.5-3)  8 19.4  7 17.7 1.1(0.5-3) 
Total 8 3.5  6 2.7   10 4.4  8 3.6  
WHO age-
adjusted 
4.5 (2-9) 
 
4 (1-8) 1.3 (0.5-3) 
 
6 (3-11) 
 
5 (2-11) 1.2 (0.6-3) 
  
Table 4: Univariable analysis of risk factors for mortality during five years after first ever stroke using Cox proportional hazards 
regression. 
Variable 
Male  Female 
Five-year death 
Hazard ratio 
(95% CI) 
 
Five-year death 
Hazard ratio 
(95% CI) 
Yes 
N (%) 
No 
N (%) 
 
 Yes 
N (%) 
No 
N (%) 
 
Age (mean±SD) 69+13.3 59.8+14.7 1.03 (1.01-1.04) 
 
70.4+13.7 57.8+13.7 1.04 (1.03-1.06) 
NIHSS at admission (mean±SD) 14.3+11.4 4.7+5.1 1.09 (1.07-1.1) 
 
14.9+11.5 5.2+5.6 1.1 (1.08-1.1) 
History of TIA before index stroke 17 (9.2) 9 (6.3) 1.4 (0.8-2.3) 
 
12 (8.2) 11 (7.4) 1.2 (0.7-2.2) 
Diabetes mellitus 60 (32.6) 37 (26.1) 1.07 (0.8-1.4)  39 (26.7) 48 (32.2) 0.8 (0.6-1.2) 
Hypertension 111 (60.3) 53 (37.3) 1.7 (1.3-2.3)  103 (70.5) 104 (69.8) 1.03 (0.7-1.5) 
Atrial fibrillation 20 (10.9) 4 (2.8) 2.3 (1.4-3.6)  21 (14.4) 7 (4.7) 2.4 (1.5-3.7) 
Hyperlipidemia 44 (23.9) 26 (18.3) 1.1 (0.8-1.6)  33 (22.6) 45 (30.2) 0.7 (0.5-1.1) 
Current smoker 26 (14.1) 35 (24.6) 1.7 (1.1-2.6)  18 (12.3) 18 (12.1) 0.9 (0.6-1.6) 
Current alcohol drinker 6 (33.) 12 (8.5) 0.5 (0.2-1.01) 
 
0 0  
Persian ethnicity 152 (82.6) 126 (88.7) 0.7 (0.5-1.04)  122 (83.6) 118 (79.2) 1.2 (0.8-1.9) 
Index stroke  
Intracerebral hemorrhage 29 (15.8) 16 (11.3) 1.3 (0.5-3.1)  20 (13.7) 15 (10.1) 1.9 (0.6-6.5) 
Ischemic stroke 145 (78.8) 118 (83.1) 0.8 (0.3-1.7)  123 (84.2) 123 (82.6) 1.4 (0.5-4.5) 
Subarachnoid hemorrhage 4 (2.2) 4 (2.8) 0.8 (0.2-2.7)  0 6 (4)  
Income  
Low annual income (< $US 2580) 98 (53.3) 66 (46.5) 1.1 (0.7-1.7)  99 (67.8) 70 (47) 3 (1.2-7.5) 
Middle annual income ($US 2580 -5160) 67 (36.4) 65 (45.8) 0.9 (0.5-1.4)  42 (28.8) 64 (43) 1.7 (0.7-4.3) 
Employment status  
Retired 52 (28.3) 33 (23.2) 1.3 (0.9-1.9)  1 (0.7) 4 (2.7) 0.5 (0.1-4) 
Disabled 4 (2.2) 3 (2.1) 1.5 (0.5-4)  2 (1.4) 0 4.1 (0.9-20) 
Unemployed 40 (21.7) 14 (9.9) 1.8 (1.2-2.6)  136 (93.2) 132 (88.6) 1.7 (0.8-3.5) 
Educated <=12 years 34 (18.5) 60 (42.3) 2 (1.4-2.9)  10 (6.8) 26 (17.4) 2.2 (1.1-4.2) 
Family history of stroke 33 (17.9) 21 (14.8) 1.2 (0.8-1.7)  28 (19.2) 29 (19.5) 1.1 (0.7-1.6) 
 
 
Figure 1: The cumulative incidence of recurrent stroke accounting for competing risk of death after 
the index first ever stroke during the 5-year study period among men and women. 
Figure 2. Kaplan-Meier curve showing the five-year probability of death among men and women 
in MSIS. 
 
 
